17Feb 2021
Antithrombotic Regimens in Low-Risk Patients Undergoing Transcatheter Aortic Valve Replacement

Antithrombotic Regimens in Low-Risk Patients Undergoing Transcatheter Aortic Valve Replacement

Choice of antithrombotic therapy folowing trans-catheter aortic valve replacement (TAVR) has been evaluated in several recent clinical trials. Initially, consensus guidelines recommended dual antiplatelet therapy with aspirin plus clopidogrel based on expert opinion. Responding to concerns regarding subdinical leaflet thrombosis raised in observational studies,

  • #cardiology

Like

Save

Share